Miracle Leaf® qualifying-conditions guide

Medical Marijuana for Fibromyalgia

Chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive symptoms. Cannabis has limited evidence for symptomatic improvement in fibromyalgia patients; pain and sleep outcomes are most commonly reported.

Reviewed by Miracle Leaf® Editorial Team

Last reviewed 2026-05-15

Book Evaluation Call (833) LEGAL-MJ

NASEM evidence levelLimitedICD-10: M79.7

What is Fibromyalgia?

Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, persistent fatigue, sleep disturbance, and cognitive symptoms ("fibro fog"). The pathophysiology involves central sensitization (abnormal pain processing in the brain and spinal cord) rather than peripheral tissue injury. Patients commonly experience tender points across multiple body regions.

Standard treatment includes exercise therapy, cognitive-behavioral therapy, and pharmacologic agents (duloxetine, milnacipran, pregabalin).

Does cannabis help Fibromyalgia?

Evidence for cannabis in fibromyalgia is limited. Several small randomized trials and observational studies of nabilone and cannabis-derived products have reported modest improvements in pain, sleep, and quality-of-life measures. Heterogeneity in study design, dosing, and outcome measures limits the strength of pooled conclusions.

Fibromyalgia is a qualifying condition under medical cannabis programs in states with broad pain qualifiers (e.g. New York, New Mexico, Illinois) or specifically enumerated chronic pain syndromes (Arkansas, Hawaii, Pennsylvania). Patients should integrate cannabis use into a broader fibromyalgia management plan rather than substitute it for evidence-based pharmacologic and behavioral therapies.

Eligibility

State eligibility for Fibromyalgia

Whether this condition is listed varies by state program. A Miracle Leaf® physician determines eligibility during your evaluation.

State-by-state eligibility for Fibromyalgia: whether the condition qualifies under Florida, Georgia, and Texas medical cannabis programs.
State	Qualifies?	Program
Florida	Not listed	Florida OMMU
Georgia	Not listed	Georgia DPH Low-THC Registry
Texas	Not listed	Texas Compassionate Use Program

Outside Florida, Georgia, or Texas?

Telehealth visits are available in 22 states. See telehealth states

Common questions

Frequently asked questions

What does the evidence say about cannabis for fibromyalgia?

Limited. The 2017 NASEM report did not identify fibromyalgia as a condition with substantial or conclusive evidence for cannabis. Small clinical trials and observational studies suggest possible improvement in pain and sleep, but trial sizes are modest and outcomes inconsistent. NIAMS does not endorse cannabis as a fibromyalgia therapy.

Is any cannabis-derived product FDA-approved for fibromyalgia?

No. No cannabis or cannabinoid product is FDA-approved for fibromyalgia. FDA-approved medications for fibromyalgia include duloxetine, milnacipran, and pregabalin. Cognitive behavioral therapy and graded aerobic exercise have the strongest non-pharmacologic evidence base.

Which forms and doses are typically used by fibromyalgia patients?

Most patient-reported use combines low-to-moderate THC products with CBD, often via oils, tinctures, or edibles for daytime symptom management and inhaled forms for breakthrough pain. Sedation, cognitive effects, and tolerance are common concerns. Cannabis interacts with antidepressants and sleep medications; disclosure to the prescribing clinician is important.

Why is fibromyalgia a qualifying condition in some states but not others?

State inclusion varies because the evidence base is limited and fibromyalgia overlaps clinically with chronic-pain and central-sensitization syndromes that are already qualifying. States such as Arkansas, Illinois, and New Mexico enumerate fibromyalgia specifically; many other states cover the same patient population under a "chronic pain" qualifier without naming fibromyalgia.

Sources and citations

Ready to talk with a Miracle Leaf® physician?

Book Evaluation Call (833) LEGAL-MJ Shop Now

Reviewed by Miracle Leaf® Editorial Team. This page summarizes current peer-reviewed evidence and federal guidance and is updated when the source documents materially change.